Random42 attending Biotech Showcase in San Francisco

Now in its 11^th year, Biotech Showcase has grown to be one of the largest and most important biotech investor conferences in the world. The event, held at the Hilton San Francisco Union Square, brings more than 3,600 decision makers from 2,200 biotech, financial, and pharma companies to network and share insights on industry trends.

This year’s agenda includes a focus on six therapeutic areas that are seeing intriguing research, innovative technologies, and the promise of transforming the way diseases are treated across the globe:

• Alzheimer’s Disease
• Cell and Gene Therapy
• Immuno-Oncology
• NASH (Nonalcoholic steatohepatitis)
• Rare and Orphan Diseases
• RNA – The year of RNA and the start of a new era

Random42 Corporate Strategy Director, Richard Grethe, and Chief Sales Officer, Louise Armstrong, will be in attendance if you would like to meet to discuss Random42's capabilities and services. Please contact us at info@random42.com to arrange a meeting.

For more information on Random42’s capabilities please see their Digital Brochure or visit the website.

For more information about Biotech Showcase please visit the website: https://ebdgroup.knect365.com/biotech-showcase/

About Random42:

A - 51 Great Marlborough Street, London, W1F 7JT
E - info@random42.com
T - +44-(0)-20-7734-6001
W - www.random42.com

Random42 Scientific Communication is a leading scientific communication studio specialising in medical animation and education, scientific virtual reality, interactive and visually engaging solutions for global pharmaceutical and biotechnology companies. Random42 produce over 200 individual digital projects each year and have won over 175 industry awards in their 26-year history - clear industry leader.